Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #618
- Final score
- 45.58
- Years on list
- 6
↘ Down 130 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 130 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 103 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 270 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | VRTX | INCY | IONS |
|---|---|---|---|
| Climate Change | 57.2 | 64.3 | 47.7 |
| Employee Relations | 48.3 | 60.5 | 35.5 |
| Environment | 40.0 | 42.0 | 48.4 |
| Stakeholders & Society | 42.4 | 34.2 | 58.4 |
| Human Rights | 34.2 | 9.9 | 16.8 |
| Governance | 39.2 | 49.4 | 44.6 |
| Performance Rating | 50.6 | 48.8 | 57.7 |